# Switching to Iloperidone From Other Antipsychotics in Schizophrenia

> **NCT01207414** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 501 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** iloperidone

## Key facts

- **NCT ID:** NCT01207414
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207414, "Switching to Iloperidone From Other Antipsychotics in Schizophrenia". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01207414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*